Pegfilgrastim biosimilar (Tianjin Pegylatt Biotechnology)

培非格司亭生物类似药(天津派格生物)

Report date: 2026/05/20 20:02:01

Base Information

Drug NamePegfilgrastim biosimilar (Tianjin Pegylatt Biotechnology)
Drug Alias Name培非司亭生物仿制药(天津派格生物)非格司亭生物仿制药(天津派格生物)聚乙二醇化重组人粒细胞集落刺激因子生物仿制药(天津派格生物)
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsFebrile NeutropeniaAgranulocytosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsFebrile NeutropeniaAgranulocytosis

Other Information

ATC CodeL03AA13
Related LinksN/A